E79.2
Myoadenylate deaminase deficiency
Clinical Classification Guidelines
Medical Intelligence & Overview
Myoadenylate deaminase deficiency is a rare inherited disorder impacting muscle function. It involves a deficiency of an enzyme called myoadenylate deaminase, which plays a key role in energy production within muscles. This condition primarily affects muscle performance, leading to muscle fatigue, pain, and weakness, especially after physical activity. Although it is a genetic disorder, many individuals may not experience noticeable symptoms. When symptoms do occur, they can vary greatly among individuals, making diagnosis sometimes challenging.
Causes & Symptoms
Clinical Causes: Genetic mutation inherited from one or both parents Deficiency of the enzyme myoadenylate deaminase due to mutations in the AMP deaminase gene Autosomal recessive inheritance pattern, meaning both copies of the gene must be affected for the condition to manifest
Key Symptoms: Muscle fatigue and weakness, especially after exercise Muscle pain or soreness following physical activity Cramps or muscle stiffness Difficulty with sustained muscle exertion Occasional episodes of muscle stiffness or cramping without clear cause Symptoms can sometimes be subtle or absent, complicating diagnosis
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a combination of clinical evaluation and laboratory testing. Doctors may perform muscle biopsies to assess enzyme activity directly. Blood tests can measure levels of muscle enzymes, and genetic testing can identify mutations in the relevant gene. Stress tests or exercise tests might also be used to evaluate how muscles respond to physical activity. Due to the similarity of symptoms with other muscle disorders, comprehensive testing and evaluation are essential for accurate diagnosis.
Treatment Protocols: Currently, there is no specific cure for myoadenylate deaminase deficiency. Treatment focuses on managing symptoms and improving quality of life. Strategies may include tailored exercise programs, physical therapy, and avoiding excessive physical exertion that triggers symptoms. Some individuals may benefit from nutritional adjustments or medications aimed at reducing muscle discomfort or fatigue, but these approaches vary and should be discussed with healthcare professionals. Regular follow-up can help monitor the condition and adjust management strategies as needed.
Clinical Advice & FAQs
Billing Guidance
Is E79.2 a billable ICD-10 code?
Yes, E79.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E79.2?
Clinical documentation must specify the nature of Myoadenylate deaminase deficiency and any associated comorbidities for accurate reporting.
Cite this Clinical Reference